Aarti Drugs

Tag: Aarti Drugs

Q1 FY26 Earnings Highlights: Key Results from Major Indian Companies

2025-07-18 Niranjan Ghatule

Q1 FY26 earnings season continues with major companies like Indian Overseas Bank, Reliance Industries, JSW Steel, Bandhan Bank, Hindustan Zinc, and others announcing their quarterly results.

Shares of Small-Cap API Manufacturer Locked in 20% Upper Circuit Following Strong Results

2025-05-07 Niranjan Ghatule

Shares of Aarti Drugs surged 20% to hit the upper circuit at Rs 420 following strong Q4 FY24 results and favorable legal relief. The company reported a sharp rise in revenue and profit continues its Rs 600 crore capex-driven growth journey. With leadership in over 50 API molecules and a robust global footprint, Aarti Drugs is positioned for long-term expansion.

Q1 FY26 Earnings Highlights: Key Results from Major Indian Companies

Shares of Small-Cap API Manufacturer Locked in 20% Upper Circuit Following Strong Results

BIS Mandates Hallmarking for 9-Carat Gold from July 2025: Here’s What It Means for Buyers and Jewelers

US Tariff Petition Hits Indian Solar Sector: Why Shares of Waaree, Premier Energies, Sterling & Wilson Fell

Jio Financial and Allianz Form 50:50 Reinsurance Joint Venture to Enter Indian Insurance Market

Today's Important Q1 Results: Strong Show by Private Banks, Mixed Performance by PSU Lenders

Dmart vs Reliance Retail: A Quick Q1 Comparison Between Two Retail Giants